Sedef Iskit, PhD,  —

Recent Posts

• High-dose efzofitimod cuts relapse rate following steroid taper
• How acute understanding of chronic pain can improve lives
• TNF-alpha inhibitors found safe, effective for cardiac sarcoidosis
• Utilizing all available tools as I seek employment with a disability
• No benefit to methotrexate over prednisolone in poor responders
• Why self-discipline is important in battling sarcoidosis
• Phase 2 trial data of namilumab for sarcoidosis expected in 2024
• Reconciling what I know about my disability status with how I feel
• MRI scans of heart may predict relapse risk with cardiac sarcoidosis
• Risk on lung transplant waitlist found higher for sarcoidosis patients